BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the Cowen 34th Annual Healthcare Conference in Boston on Tuesday, March 4, 2014 at 10:40 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
